Orthopedics This Week

icotec Receives CMS approval for New Technology Add-On Payment for its CMORE® CT System

NTAP effective October 1, 2026, expanding access to icotec’s radiolucent spinal stabilization technology for eligible Medicare procedures.

DiscGenics Announces Leadership Transition as IDCT Advances Through Pivotal Phase III Development

Medacta Strengthens its Capital Markets and Communications Leadership with the Appointment of Riccardo Fava as New Group VP Investor Relations, Sustainability & Media Relations

Medacta Group SA today announces the appointment of Riccardo Fava as Group VP Investor Relations, Sustainability & Media Relation.

Worldwide First: Biedermann Motech Further Expands its MOSS!MODULARITY Platform with the Addition of MOSS EOS for Early Onset Scoliosis Surgery

Biedermann Motech today announced the selective market introduction of the MOSS EOS® System for the treatment of children with severe early onset scoliosis.

Consano Bio Raises More Than $15 Million in Oversubscribed Financing to Advance C-1101 in Chronic Painful Lumbosacral Radiculopathy (Chronic Sciatica)

Proceeds will fund completion of the Phase 1 trial and continued development of C-1101, a potential first-in-class disease-modifying therapeutic -- Clinical data expected in 1H 2027.

Pacira Announces Exclusive Agreement with Molteni Farmaceutici to Commercialize EXPAREL® in the European Union and United Kingdom

Pacira BioSciences today announced a strategic partnership with Molteni Farmaceutici to expand access to opioid-sparing postsurgical pain management across European markets.

New Study Puts MRI to the Bone Quality Test

Is your bone quality MRI scan lying to you?

Surgery or Conservative Care? Elderly Distal-Humerus Fracture Study

Surgery or conservative care for the over-80 distal humerus fracture patient?

Medicare’s 2027 Payment Proposal: Squeeze Until it Hurts

How will CMS’ payment changes affect your practice?

A New Blue Cross Study Says AI Documentation Tools Are Inflating Claims. For Orthopedic Practices, That's A Reason to Adopt AI Now

PearlMatrix® P-15 Peptide Enhanced Bone Graft Receives Medicare New Technology Add-on Payment (NTAP), Helping Hospitals Accelerate Lumbar Fusion

NTAP provides additional Medicare reimbursement to hospitals using PearlMatrix, the first and only bone growth accelerator demonstrating superior lumbar fusion speed.

CONMED Corporation to Report Third Quarter 2026 Financial Results on October 28, 2026

CONMED announced that it will report financial results for the third quarter 2026 after the market close on Wednesday, October 28, 2026.